|CIBER-BBN (coordinator group)||Jordi Aguiló, GBIO-CNM|
|CIBER-BBN||Jose Javier Serrano, GBT-UPM|
|SEPAR||Joan A. Caylá, PII TB|
|CIBERES||Joan Ruiz Manzano, Germans Trias i Pujol Hospital|
Adherence to Tuberculosis (TB) treatment or other long lasting treatments is a key success parameter with significant impact in the avoidance of drug resistance and patient relapses. A supervisory system may be very useful in cases where compliance to drug-clinical trials is questionable or abuse is very likely.
AD4AD is aiming to design a system capable of controlling and supporting patients´ adherence to long-lasting treatments. It consists of three main lines of technological R+D: